This observational follow-up study of the randomized trial (RCT) DIQOL investigates long-term effects of an intervention with quality of life (QoL) diagnosis and therapy on present QoL, survival, and recurrence-free survival of colorectal cancer survivors more than 5 years after surgery. Moreover, patients' experiences with aftercare for colorectal cancer during the COVID-19 pandemic and their recollections of their illness and therapy are examined.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
need for QoL therapy of colorectal cancer survivors
Timeframe: >5 years after surgery for colorectal cancer
specific need for QoL therapy of colorectal cancers survivors in specific QoL dimensions
Timeframe: >5 years after surgery for colorectal cancer